Neal Shore, MD on Phase III ARAMIS Study of DARO for nmCRPC #ASCO2020 @UNCurology

Neal Shore, MD on Phase III ARAMIS Study of DARO for nmCRPC #ASCO2020 @UNCurology

User Photo
Cancer-News

4 weeks
21 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Neal Shore, MD of Carolina Urologic Research Center @UNCurology discusses the overall survival results of phase III ARAMIS study of darolutamide added to androgen deprivation therapy for nonmetastatic castration-resistant prostate cancer presented at this year's virtual ASCO.

Read here: https://meetinglibrary.asco.org/record/187482/abstract

Up Next Autoplay
User Photo